ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,117 | -22.0% | 16,383 | 0.0% | 0.00% | – |
| Q2 2023 | $127,132 | +68.8% | 16,383 | +16.2% | 0.00% | – |
| Q1 2022 | $75,321 | -69.8% | 14,105 | -16.8% | 0.00% | – |
| Q4 2021 | $249,000 | -26.3% | 16,961 | +4.9% | 0.00% | – |
| Q3 2021 | $338,000 | +12.3% | 16,163 | -5.0% | 0.00% | – |
| Q2 2021 | $301,000 | -4.7% | 17,018 | +32.1% | 0.00% | – |
| Q1 2021 | $316,000 | -27.7% | 12,878 | -0.2% | 0.00% | – |
| Q4 2020 | $437,000 | – | 12,907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |